MAP3K13 Antikörper (AA 506-835) (FITC)
Kurzübersicht für MAP3K13 Antikörper (AA 506-835) (FITC) (ABIN7160027)
Target
Alle MAP3K13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 506-835
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Mitogen-activated protein kinase kinase kinase 13 protein (506-835AA)
-
Isotyp
- IgG
-
-
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (AA 711-810) antibody
MAP3K13 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 4H7 unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (N-Term) antibodyMAP3K13 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (AA 506-835) antibodyMAP3K13 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (Internal Region) antibodyMAP3K13 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (AA 801-900) antibodyMAP3K13 Reaktivität: Human, Maus WB, ELISA, IF (cc), IF (p), IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (AA 854-884), (C-Term) antibodyMAP3K13 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB12383 unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (AA 1-966) antibodyMAP3K13 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (AA 1-966) antibodyMAP3K13 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13) (Internal Region) antibodyMAP3K13 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
Andere Bezeichnung
- MAP3K13
-
Hintergrund
-
Background: Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
Aliases: EC 2.7.11.25 antibody, Leucine zipper bearing kinase antibody, Leucine zipper-bearing kinase antibody, LZK antibody, M3K13_HUMAN antibody, MAP3K13 antibody, MEKK13 antibody, MGC133196 antibody, Mitogen activated protein kinase kinase kinase 13 antibody, Mitogen-activated protein kinase kinase kinase 13 antibody, Mixed lineage kinase antibody, MLK antibody, OTTHUMP00000210397 antibody
-
UniProt
- O43283
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
Target
-
